Search
Search

Author

sysadmin

Publish date

I have something to tell you about deCODE–there’s good news and there’s bad news.

genetics.gif

First, for the good news: today deCODE announced that it has filed an IND with the FDA for a new drug on cognition designed to combat memory loss and the other effects of Alzheimer’s disease. The compound DG071 has shown promise in animal models and while it doesn’t rebuild or restore neurons, it aims to “llow the remaining neurons to store and retrieve memories more efficiently”.

Now, for the bad news: Nasdaq announced that deCODE was given a slap on the wrist for falling below the minimum value of common stock being traded (that minimum being a mere $50 million) nor is the company worth enough overall to continue being listed on Nasdaq’s Global Market. deCODE has 30 days to rake in the big bucks or it’s out of the Nasdaq Global Market and will fall to the Capital Market.

Looks like this drug had better be a blockbuster.

Summer Johnson, PhD

Related posts

Guns, Insurance, and the Political Determinants of Health

In the United States, where gun controls are far too few and unchecked guns are generally okay, even celebrated, such political determinants of health have constantly terrible impacts. Guns have one purpose: to kill. Such political determinants of health have determined that anyone can be shot dead or injured with a gun at any point […]

Off the Shelf and into Practice—Maybe

In September, the World Health Organization (WHO) released new guidance on best practices for clinical trials. The 76-page guidance document, called for by a resolution adopted by the 2022 World Health Assembly, seeks to improve the design, conduct, and oversight of clinical trials globally. Building upon guidance from the Council of International Organizations of Medical […]

The Danger of Conflating the Russian Scientific Community with Putin’s Regime in Global Bioethics

  The global bioweapons regime stands at a pivotal point where collaboration or conflict can determine the future of bioethical standards and international security. A recent sign pointing toward conflict is the North Atlantic Treaty Organization’s Biotechnology and Human Enhancement Technologies Strategy, which singles Russia as a bad actor. Such an approach not only risks […]

Clinical Decision Support Systems: Pop-ups And Prescribing Practices

Clinicians increasingly rely on AI-driven clinical decision support systems. One important facet of decision support systems is the pop-up notification. Clinicians see pop-ups in their electronic health records (EHR) systems. Pop-up alerts may add consistency to patient care and even promote safety, but they may also contribute to medicalization, overprescribing, and unsafe prescribing and be […]

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.

close